Vitespen Recruiting Phase 1 Trials for Astrocytoma, Grade III / Glioblastoma Multiforme (GBM) / Clear Cell Ependymoma / Ependymomas / Anaplastic Ependymoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02722512Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine